arginine and Prostatic Neoplasms, Castration-Resistant

arginine has been researched along with Prostatic Neoplasms, Castration-Resistant in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Ann, DK; Changou, CA; Chen, CL; Chen, HW; Cheng, ML; Chu, CY; Chuu, CP; Hsu, SC; Kung, HJ; Kuo, CC; Kuo, TC; Li, CF; Wang, HJ; Wang, LH; Yeh, SD; Yen, Y; Yu, YL1
Bessudo, A; Cheng, PNM; Liu, AM; Mussai, F1

Trials

1 trial(s) available for arginine and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Safety, PK/PD and preliminary anti-tumor activities of pegylated recombinant human arginase 1 (BCT-100) in patients with advanced arginine auxotrophic tumors.
    Investigational new drugs, 2021, Volume: 39, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Arginase; Arginine; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Male; Melanoma; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Recombinant Proteins; Skin Neoplasms

2021

Other Studies

1 other study(ies) available for arginine and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Arginine starvation elicits chromatin leakage and cGAS-STING activation via epigenetic silencing of metabolic and DNA-repair genes.
    Theranostics, 2021, Volume: 11, Issue:15

    Topics: Arginine; Chromatin; DNA Repair; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Membrane Proteins; Neoplasm Proteins; Nucleotidyltransferases; PC-3 Cells; Prostatic Neoplasms, Castration-Resistant

2021